Induced fit versus conformational selection: From rate constants to fluxes… and back to rate constants

by Georges Vauquelin, Dominique Maes
Published 2021-10-01

Review: Structural requirements for signalling and regulation of AT1-receptors

by László Hunyady, Zsuzsanna Gáborik, Georges Vauquelin, Kevin J Catt
Published 2001-03-01

Distinctions between non-peptide angiotensin II AT1-receptor antagonists

by Georges Vauquelin, Frederik LP Fierens, Ilse Verheijen, Patrick ML Vanderheyden
Published 2001-03-01

Cellular targets for angiotensin II fragments: pharmacological and molecular evidence

by Georges Vauquelin, Yvette Michotte, Ilse Smolders, Sophie Sarre, Guy Ebinger, Alain Dupont, Patrick Vanderheyden
Published 2002-12-01

Binding characteristics of [3H]-irbesartan to human recombinant angiotensin type 1 receptors

by Patrick ML Vanderheyden, Ilse Verheijen, Frederik LP Fierens, Jean-Paul De Backer, Georges Vauquelin
Published 2000-06-01

Role of basic amino acids of the human angiotensin type 1 receptor in the binding of the non-peptide antagonist candesartan

by Georges Vauquelin, Frederik LP Fierens, Zsuzsanna Gáborik, Tam Le Minh, Jean-Paul De Backer, László Hunyady, Patrick ML Vanderheyden
Published 2001-03-01

Lys 199 mutation of the human angiotensin type 1 receptor differentially affects the binding of surmountable and insurmountable non-peptide antagonists

by Frederik LP Fierens, Patrick ML Vanderheyden, Zsuzsanna Gáborik, Tam Le Minh, Jean-Paul De Backer, László Hunyady, Adriaan Ijzerman, Georges Vauquelin
Published 2000-09-01

Mechanisms of PDZ domain scaffold assembly illuminated by use of supported cell membrane sheets

by Simon Erlendsson, Thor Seneca Thorsen, Georges Vauquelin, Ina Ammendrup-Johnsen, Volker Wirth, Karen L Martinez, Kaare Teilum, Ulrik Gether, Kenneth Lindegaard Madsen
Published 2019-01-01